A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.Nehal J. Lakhani, Kathleen N. Moore, John B. Liao et al.|Journal of Clinical Oncology|2020Cited by 37
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerJohn B. Liao, Mary L. Disis|Journal for ImmunoTherapy of Cancer|2015Cited by 31